title: Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
authors.affiliation: Group of Psychiatric Neuroscience, Department of Neuroscience and Sense Organs, University of Bari Bari, Italy IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo (FG), Italy Group of Psychiatric Neuroscience Department of Neuroscience and Sense Organs University of Bari Bari, Italy Group of Psychiatric Neuroscience, Department of Neuroscience and Sense Organs, University of Bari Bari, Italy and IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo (FG), Italy Group of Psychiatric Neuroscience Department of Neuroscience and Sense Organs University of Bari Bari, Italy Eli Lilly Italia S.p.A., Sesto Fiorentino, Florence, Italy Group of Psychiatric Neuroscience, Department of Neuroscience and Sense Organs, University of Bari Bari, Italy and IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo (FG), Italy a.bertolino@psichiat.uniba.it.
authors.forename: Grazia
authors.initials: G
authors.lastname: Caforio
authors.forename: Annabella
authors.initials: A
authors.lastname: Di Giorgio
authors.forename: Antonio
authors.initials: A
authors.lastname: Rampino
authors.forename: Miriam
authors.initials: M
authors.lastname: Rizzo
authors.forename: Raffaella
authors.initials: R
authors.lastname: Romano
authors.forename: Paolo
authors.initials: P
authors.lastname: Taurisano
authors.forename: Leonardo
authors.initials: L
authors.lastname: Fazio
authors.forename: Giuseppe
authors.initials: G
authors.lastname: De Simeis
authors.forename: Gianluca
authors.initials: G
authors.lastname: Ursini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Blasi
authors.forename: Marcello
authors.initials: M
authors.lastname: Nardini
authors.forename: Michele
authors.initials: M
authors.lastname: Mancini
authors.forename: Alessandro
authors.initials: A
authors.lastname: Bertolino
mesh_terms: D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008803:Mianserin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D012565:Schizophrenic Psychology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D008803:Mianserin; D000078785:Mirtazapine; D000077152:Olanzapine